Human papillomavirus (HPV) testing is highly sensitive compared to cytology, with the trade-off of being less specific. We investigated whether select combinations of HPV genotypes, ascertained by Linear Array (LA) and Xpert HPV (GX), can optimize sensitivity/specificity trade-offs to detect high-grade cervical intraepithelial neoplasia (CIN2+). In a study in Cape Town, South Africa, 586 women living without and 535 living with HIV, aged 30-65 years, were recruited. Each woman underwent a pelvic exam to collect cervical samples (tested by LA and GX for 14 high-risk HPV genotypes) and underwent colposcopy with histological sampling to determine CIN2+. In multivariable logistic regression of LA results, only HPV genotypes 16, 18, 31, 33, 35, 52, 58 were significantly associated with CIN2+ (P
CITATION STYLE
Johnson, L. G., Saidu, R., Mbulawa, Z., Williamson, A. L., Boa, R., Tergas, A., … Kuhn, L. (2020). Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women. Cancer Medicine, 9(18), 6813–6824. https://doi.org/10.1002/cam4.3329
Mendeley helps you to discover research relevant for your work.